Work

Healthcare Resource Utilization and Medical Costs in Patients with Ulcerative Colitis Based on Therapy Response to Advanced Therapy: A Descriptive Analysis of German Healthcare Claims Data

Year: 2025

Type: conference-paper

Abstract: Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes significant morbidity and impaired quality of life [ref:1]. In Germany, approximately 5.3 per 1,000 adults are affected [ref:2]. Recent studies showed that most adult patients initiating advanced [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/25gmds159

Authors: Dignass, Axel, Blumenstein, Irina, Schwedhelm, Carolina, Strassen, Katrin, Kunk, Leonie, Marquardt, Sophie, Seiffert, Anna, Kulchytska, Nataliia, Benson, Alexa, Kisser, Agnes

Institutions: Agaplesion Markus Hospital, Goethe University Frankfurt, University Hospital Frankfurt, Pfizer (Germany)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Pfizer

OpenAlex ID: W7103882014

FWCI:

Cites:

Cited by:

Related to: